Bangi, Selangor, July 17, 2019 – Duopharma Biotech Berhad (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma Biotech”)’s commitment in enhancing halal integrity for pharmaceutical products continues to attract the interest of various groups in Malaysia, with the latest being the visit by the Negeri Sembilan Mufti and Fatwa office led by the mufti himself, Datuk Hj Mohd Yusof Bin Hj. Ahmad.
Duopharma Biotech is currently the market leader in the local halal pharmaceutical sector that advocates halal pharmaceuticals among consumers. The engagement with the Negeri Sembilan Mufti and Fatwa office reflected the Company’s dedication in not only ensuring that its manufacturing processes are in accordance with Shariah principles but also sharing the latest industry updates with the relevant authorities.
During the visit, Datuk Hj Mohd Yusof led a delegation of 25 people including the Negeri Sembilan Deputy Mufti, Amran Awaludin; and Chairman of the Majlis Agama Islam Negeri Sembilan (MAINS), Datuk Haji Mohamed Haji Husein, who spent close to two hours touring the manufacturing facility in Bangi to understand the complexity behind the manufacturing of halal pharmaceutical products.
Wan Amir-Jeffery Wan Abdul Majid, Chief Operating Officer of Duopharma Biotech led the Company’s senior management to brief the delegation on its halal manufacturing processes.
“The adherence to halal standards would give Duopharma Biotech a strategic advantage to the enormous opportunities that remain largely untapped in the halal pharmaceutical industry and increasing demand for halal products amongst global communities.
“More importantly, fulfilling the patients’ religious beliefs in looking for the purest and halal ingredients used in making of pharmaceuticals besides ensuring the safety, effectiveness, quality and cleanliness of the products,” said Wan Amir-Jeffery.
Duopharma Biotech is the first pharmaceutical company in Malaysia to receive the Halal Pharmaceuticals Certification based on the world’s first Halal Pharmaceuticals Standard: MS2424:2012 “Halal Pharmaceuticals – General Guidelines” and is also listed in the Malaysia Book of Records in 2013. The Company is also the recipient of the 2018 Frost & Sullivan award for the Malaysian “Pharmaceutical Company of the Year”.
In order to receive the halal certifications, the pharmaceutical products must first fulfil the requirements of the Good Manufacturing Practices (GMP) before meeting additional prerequisites for halal certification, hence, setting a higher benchmark for quality.
Datuk Hj Mohd Yusof was pleased with Duopharma Biotech’s safe and hygienic manufacturing environment and will share the knowledge gained from the visit with the Negeri Sembilan Fatwa Council so that they are able to better explain the complexity behind the manufacturing of these products to Muslim consumers in Negeri Sembilan.
“At this point in time, most Muslims would accept the pharmaceutical products as halal based on the advertising claims made by the manufacturers. As the Muslim community is becoming more discerning and demanding about the medicine that they are taking, including its halal-ness, safety, efficacy and cleanliness, they will soon be requesting for products that carry the halal logo certified by the relevant authority.
“Although Muslims are allowed to consume pharmaceutical products that are not halal-certified due to the absence of similar halal products, local pharmaceutical manufacturers should take the initiative to research and develop the halal version of these products which will be much appreciated by the Muslim community.
“I would like to thank Duopharma Biotech for providing this opportunity and truly appreciate the Company’s commitment in providing high standard and quality halal pharmaceutical products. I sincerely hope that other pharmaceutical companies would strive for the halal certification and together improve the society’s quality of life,’’ said Datuk Hj Mohd Yusof.
Malaysia is currently the global leader in the certified halal pharmaceutical industry as it is the only nation that has a standard to manufacture certified halal pharmaceuticals in the world.
The rising options in halal pharmaceutical products have also shifted local pharmaceutical players to become more competitive in penetrating the global halal industry, especially in the lucrative Muslim nations.